Developer docs
API playgroundTry for free, no card

Search company profiles

Bullpup Scientific

Full company profile

uuid000zv2y

Namestring
Bullpup Scientific
Legal namestring
Bullpup Scientific ltd.
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Bullpup Scientific is a privately held medical device company founded in 2015, with operating presence in Haifa, Israel and a legal entity registered as Bullpup Scientific ltd. The company develops IV access solutions centered on a single product platform: the M/29 Bullpup Midline IV Catheter System, a safety IV catheter featuring standard over-the-needle insertion procedure and a single cannula capable of up to 29 days of dwell time. Product variants include the original M/29 Bullpup and the enhanced M/29 PRO. The device addresses the clinical gap between standard short-term IV cannulas (48–72 hour dwell time) and longer-term central venous access options such as PICC lines, targeting hospitalized patients whose length of stay typically exceeds 2–3 days.

The catheter's technical design includes a notched needle for rapid blood visualization during insertion, ultrasound-guided placement compatibility for deeper vein access, gauges ranging from 18 to 22, and a 325 PSI pressure rating supporting high-flow injection applications. Company leadership consists of co-founder and COO Ronen Radomski; no additional management, board, or scientific advisory personnel are disclosed in public sources.

Bullpup Scientific operates a B2B enterprise field sales model targeting hospital procurement and clinical departments, selling catheters as physical hardware. Revenue is generated through direct medical device sales, though pricing and unit volumes are not publicly disclosed. The marketing approach emphasizes downloadable brochures, training resources, instruction-for-use documents, and participation in industry conferences (notably WoCoVA 2020). No distribution partnerships, regulatory clearances, certifications, patents, or institutional investors are documented in available sources.

Short descriptiontext

Bullpup Scientific is a privately held medical device company founded in 2015 that develops the M/29 Bullpup Midline IV Catheter System, a single-cannula safety catheter with up to 29 days of dwell time, targeting hospitals treating patients with extended length of stay.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersHaifa, Israel
HQ citystring
Haifa
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Keyword5 values
midline IV catheters, vascular access devices, extended dwell catheters, medical device manufacturing, safety IV catheters
Industry3 codes
1Infusion Sets, Catheters & Pump Consumables
CodeHLAHAIAHPrimaryYes
2Urinary Catheters & Drainage (Intermittent/Foley Catheters, Bags, Securement)
CodeHLAHALAIPrimaryNo
3IV Therapy, Infusion & Fluid Management (Pumps, Catheters, Fluid Sets)
CodeHLAMAFAGPrimaryNo
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Vascular Access Devices
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Sale of the M/29 Bullpup Midline IV Catheter System and related accessories to healthcare facilities. Single cannula product with extended 29-day dwell time represents a displacement product for standard IV cannulas.

bullpupscientific.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1M/29 Bullpup
Description

Midline IV catheter system with single cannula for up to 29 days dwell time. Features standard over-the-needle insertion procedure.

bullpupscientific.com
+1 more record
Core offering1 text field

Bullpup Scientific designs, develops, and manufactures IV catheter systems, principally the M/29 Bullpup Midline IV Catheter System and its enhanced M/29 PRO variant, which deliver an industry-leading 29-day extended dwell time for hospitalized patients with extended length of stay. The devices use a notched-needle, over-the-needle insertion technique compatible with standard procedures and high-pressure injection up to 325 PSI.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Dwell time extended from 48-72 hours to up to 29 days with single cannula
Product overview1 text field

Bullpup Scientific offers a focused portfolio of medical devices centered on the M/29 Bullpup™ IV catheter system, which includes the original M/29 Bullpup and the newer M/29 PRO variant. Both products are safety IV catheters designed for extended dwell times, with the core innovation being a single over-the-needle insertion that can last up to 29 days, addressing the gap in IV access for hospitalized patients with stays longer than 2-3 days.

Product and service2 records
1M/29 Bullpup Midline IV Catheter System
CategoryVascular Access Devices
Description

An extended-dwell midline IV catheter system that delivers up to 29 days of peripheral IV access for hospitalized patients with extended length of stay, inserted using a standard over-the-needle technique and rated for high-pressure injection up to 325 PSI for contrast imaging.

2M/29 PRO
CategoryVascular Access Devices
Description

Enhanced version of the M/29 Bullpup Midline IV Catheter System offering the same 29-day extended dwell time with the company's latest refinements for hospitalized patients requiring long-duration IV access.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers9 records
TypeBroad incumbent
Description

Global leader in IV catheter and vascular access products (e.g., BD Nexiva, BD Insyte Autoguard). While broader than Bullpup's midline niche, BD is the dominant incumbent that Bullpup must displace or be acquired by in hospital accounts.

TypeDirect peer
Description

Specializes in single-use medical devices for neonates, anesthesia, and IV access, including midlines (e.g., Lifecath midline). Highly comparable in product focus on extended-dwell vascular access and similar customer base.

TypeDirect peer
Description

Manufactures IV therapy products and acquired Smiths Medical, expanding its catheter portfolio. Competes directly in the IV catheter space and is a likely candidate to either compete with or acquire a midline-focused entrant like Bullpup.

TypeBroad incumbent
Description

Broad medical device manufacturer with vascular access product lines including catheters. Comparable customer overlap in hospitals though operates across many device categories beyond IV access.

TypeBroad incumbent
Description

Major IV catheter manufacturer (Introcan Safety, Vasofix) with a global hospital sales footprint. Directly comparable in product category and customer base to Bullpup's M/29, though at much larger scale.

TypeDirect peer
Description

Offers Arrow branded vascular access devices including midlines and PICCs (Arrow Arterial Catheterization, Arrow Midline). Closely comparable to Bullpup in targeting the extended-dwell vascular access segment.

TypeBroad incumbent
Description

Through its vascular devices portfolio, Abbott serves hospital vascular access needs. While broader than Bullpup, it represents the scale of incumbent competitor that hospital procurement committees already work with.

8MedComp
TypeDirect peer
Description

Specializes in vascular access devices including midlines and PICCs (e.g., ProLine midline). Comparable niche focus on extended-dwell IV access serving similar hospital customers.

TypeDirect peer
Description

Vascular access portfolio includes BioFlo midlines and PICCs. Directly competes in the midline catheter segment with extended-dwell claims similar to Bullpup's M/29.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bullpup Scientific

Vascular Access Devicesbullpupscientific.com

Bullpup Scientific is a privately held medical device company founded in 2015 that develops the M/29 Bullpup Midline IV Catheter System, a single-cannula safety catheter with up to 29 days of dwell time, targeting hospitals treating patients with extended length of stay.

What Bullpup Scientific does

Bullpup Scientific is a privately held medical device company founded in 2015, with operating presence in Haifa, Israel and a legal entity registered as Bullpup Scientific ltd. The company develops IV access solutions centered on a single product platform: the M/29 Bullpup Midline IV Catheter System, a safety IV catheter featuring standard over-the-needle insertion procedure and a single cannula capable of up to 29 days of dwell time. Product variants include the original M/29 Bullpup and the enhanced M/29 PRO. The device addresses the clinical gap between standard short-term IV cannulas (48–72 hour dwell time) and longer-term central venous access options such as PICC lines, targeting hospitalized patients whose length of stay typically exceeds 2–3 days.

The catheter's technical design includes a notched needle for rapid blood visualization during insertion, ultrasound-guided placement compatibility for deeper vein access, gauges ranging from 18 to 22, and a 325 PSI pressure rating supporting high-flow injection applications. Company leadership consists of co-founder and COO Ronen Radomski; no additional management, board, or scientific advisory personnel are disclosed in public sources.

Bullpup Scientific operates a B2B enterprise field sales model targeting hospital procurement and clinical departments, selling catheters as physical hardware. Revenue is generated through direct medical device sales, though pricing and unit volumes are not publicly disclosed. The marketing approach emphasizes downloadable brochures, training resources, instruction-for-use documents, and participation in industry conferences (notably WoCoVA 2020). No distribution partnerships, regulatory clearances, certifications, patents, or institutional investors are documented in available sources.

Bullpup Scientific firmographics

Firmographics
Name
Bullpup Scientific
Legal name
Bullpup Scientific ltd.
Website
https://bullpupscientific.com
Company type
Private
Founded year
2015
Operating status
Operating
Short description
Bullpup Scientific is a privately held medical device company founded in 2015 that develops the M/29 Bullpup Midline IV Catheter System, a single-cannula safety catheter with up to 29 days of dwell time, targeting hospitals treating patients with extended length of stay.
Ownership category
akta.pro rank

Bullpup Scientific industry classification

Industry
Product category
Vascular Access Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Infusion Sets, Catheters & Pump Consumables (HLAHAIAH)
akta.pro secondary industries
Urinary Catheters & Drainage (Intermittent/Foley Catheters, Bags, Securement) (HLAHALAI), IV Therapy, Infusion & Fluid Management (Pumps, Catheters, Fluid Sets) (HLAMAFAG)

Keywords

  • Midline IV catheters
  • Vascular access devices
  • Extended dwell catheters
  • Medical device manufacturing
  • Safety IV catheters

Where Bullpup Scientific is headquartered

Location

Headquarters

HQ city
Haifa
HQ country
Israel
HQ region
Middle East

Markets served

Bullpup Scientific business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Medical Device Sales: Sale of the M/29 Bullpup Midline IV Catheter System and related accessories to healthcare facilities. Single cannula product with extended 29-day dwell time represents a displacement product for standard IV cannulas.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Bullpup Scientific product offering

Product offering

Core offering

Bullpup Scientific designs, develops, and manufactures IV catheter systems, principally the M/29 Bullpup Midline IV Catheter System and its enhanced M/29 PRO variant, which deliver an industry-leading 29-day extended dwell time for hospitalized patients with extended length of stay. The devices use a notched-needle, over-the-needle insertion technique compatible with standard procedures and high-pressure injection up to 325 PSI.

Product overview

Bullpup Scientific offers a focused portfolio of medical devices centered on the M/29 Bullpup™ IV catheter system, which includes the original M/29 Bullpup and the newer M/29 PRO variant. Both products are safety IV catheters designed for extended dwell times, with the core innovation being a single over-the-needle insertion that can last up to 29 days, addressing the gap in IV access for hospitalized patients with stays longer than 2-3 days.

Differentiator

Problem solved

Functional benefit

Brands

  • M/29 Bullpup: Midline IV catheter system with single cannula for up to 29 days dwell time. Features standard over-the-needle insertion procedure.
  • M/29 PRO

Products and services

  • M/29 Bullpup Midline IV Catheter System An extended-dwell midline IV catheter system that delivers up to 29 days of peripheral IV access for hospitalized patients with extended length of stay, inserted using a standard over-the-needle technique and rated for high-pressure injection up to 325 PSI for contrast imaging.
  • M/29 PRO Enhanced version of the M/29 Bullpup Midline IV Catheter System offering the same 29-day extended dwell time with the company's latest refinements for hospitalized patients requiring long-duration IV access.

Quantifiable outcome

  • Dwell time extended from 48-72 hours to up to 29 days with single cannula

Companies that use Bullpup Scientific

Customer profile

Segments1 record

Ideal customer profiles1 record

Bullpup Scientific technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Bullpup Scientific partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves3 records

Expansion highlights3 records

Bullpup Scientific competitors and assessment

Company assessment

Broad incumbents

  • Becton, Dickinson and Company (BD): Global leader in IV catheter and vascular access products (e.g., BD Nexiva, BD Insyte Autoguard). While broader than Bullpup's midline niche, BD is the dominant incumbent that Bullpup must displace or be acquired by in hospital accounts.
  • Cook Medical: Broad medical device manufacturer with vascular access product lines including catheters. Comparable customer overlap in hospitals though operates across many device categories beyond IV access.
  • B. Braun: Major IV catheter manufacturer (Introcan Safety, Vasofix) with a global hospital sales footprint. Directly comparable in product category and customer base to Bullpup's M/29, though at much larger scale.
  • Abbott: Through its vascular devices portfolio, Abbott serves hospital vascular access needs. While broader than Bullpup, it represents the scale of incumbent competitor that hospital procurement committees already work with.

Direct peers

  • Vygon: Specializes in single-use medical devices for neonates, anesthesia, and IV access, including midlines (e.g., Lifecath midline). Highly comparable in product focus on extended-dwell vascular access and similar customer base.
  • ICU Medical: Manufactures IV therapy products and acquired Smiths Medical, expanding its catheter portfolio. Competes directly in the IV catheter space and is a likely candidate to either compete with or acquire a midline-focused entrant like Bullpup.
  • Teleflex: Offers Arrow branded vascular access devices including midlines and PICCs (Arrow Arterial Catheterization, Arrow Midline). Closely comparable to Bullpup in targeting the extended-dwell vascular access segment.
  • MedComp: Specializes in vascular access devices including midlines and PICCs (e.g., ProLine midline). Comparable niche focus on extended-dwell IV access serving similar hospital customers.
  • AngioDynamics: Vascular access portfolio includes BioFlo midlines and PICCs. Directly competes in the midline catheter segment with extended-dwell claims similar to Bullpup's M/29.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Bullpup Scientific financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bullpup Scientific leadership team

Management profile

Number of profiles

Profiles1 record

Bullpup Scientific funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bullpup Scientific M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bullpup Scientific

What does Bullpup Scientific do?

Bullpup Scientific designs, develops, and manufactures IV catheter systems, principally the M/29 Bullpup Midline IV Catheter System and its enhanced M/29 PRO variant, which deliver an industry-leading 29-day extended dwell time for hospitalized patients with extended length of stay. The devices use a notched-needle, over-the-needle insertion technique compatible with standard procedures and high-pressure injection up to 325 PSI.

Is Bullpup Scientific a public or private company?

Bullpup Scientific is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Bullpup Scientific founded?

Bullpup Scientific was founded in 2015.

Where is Bullpup Scientific based?

Bullpup Scientific is headquartered in Haifa, Israel, in the Middle East region.

How does Bullpup Scientific make money?

One revenue line is on record: medical Device Sales.

Who are Bullpup Scientific's main competitors?

Broad incumbents on record are Becton, Dickinson and Company (BD), Cook Medical, B. Braun and Abbott. Direct peers are Vygon, ICU Medical, Teleflex, MedComp and AngioDynamics.

Does Bullpup Scientific have an API?

No public API is recorded for Bullpup Scientific.

What industry is Bullpup Scientific in?

Bullpup Scientific's product category is Vascular Access Devices. Its primary akta.pro industry code is HLAHAIAH, Infusion Sets, Catheters & Pump Consumables, with a secondary code of HLAHALAI, Urinary Catheters & Drainage (Intermittent/Foley Catheters, Bags, Securement). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales